Deux protocoles d’hyperimmunisation au moyen de vaccins marqués réduisent l’incidence de séroconversion envers l’herpèsvirus bovin 1 en cheptels laitiers : résultats d’une étude sur le terrain
Dispas, M.; Lemaire, Mylène; Speybroeck, N.et al.
2004 • In Annales de Médecine Vétérinaire, 148 (1), p. 47-61
[en] A 28 months long cohort study was organized in dairy herds in Belgium, to assess the efficacy of hyperimmunisation as a tool for the control of infectious bovine rhinotracheitis. Two protocols of hyperimmunisation in which glycoprotein-E deleted marker vaccines were repeatedly administered were compared to a positive control group in which the usual vaccination protocols were authorised. The two hyperimmunisation protocols differed in the primovaccination : the first group was treated with an attenuated vaccine firstly given intra-nasally then by intramuscular route whereas the second group was given an inactivated vaccine by subcutaneous injection. Afterwards, booster vaccinations were the same in both groups : an inactivated vaccine was administered by subcutaneous route every 6 months. In the control group, as a rule, part of the herd was vaccinated annually. For each group, 6 half-yearly reports specify : 1. the evolution of the population, categorized by birth half-year, 2. the incidence of seroconversion against gE in the cohorts and 3. the evolution of the gE seroprevalence. The survival curves of the hyperimmunised groups show a significantly higher proportion (P < 0,001) of animals remaining seronegative against glycoprotein- E compared to the positive control group. No significant difference was shown between the two protocols of hyperimmunisation. Both of them could then be used as tools for the control of infectious bovine rhinotracheitis.
Disciplines :
Microbiology Veterinary medicine & animal health
Author, co-author :
Dispas, M.
Lemaire, Mylène
Speybroeck, N.
Berkvens, D.
Merveille, Anne ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Boelaert, F.
Dramaix, M.
Vanopdenbosch, E.
Kerkhofs, P.
Thiry, Etienne ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires > Virologie, épidémiologie et pathologie des maladies virales
Language :
French
Title :
Deux protocoles d’hyperimmunisation au moyen de vaccins marqués réduisent l’incidence de séroconversion envers l’herpèsvirus bovin 1 en cheptels laitiers : résultats d’une étude sur le terrain
ANDERSON R. The concept of herd immunity and the design of community-based immunization programmes. Vaccine, 1992, 10, 928-935.
Directive 64/432/CEE du Conseil, du 26 juin 1964, relative à des problèmes de police sanitaire en matière d'échanges intracommunautaires d'animaux des espèces bovine et porcine. Journal officiel, 1964, 121, 1977-2012. Adresse URL: http://www.adminet.com/eur/loi/ leg_euro/fr_364L0432.html Consulté le 30/01/03.
BLAND J.M., ALTMAN D.G. Multiple significance tests the Bonferroni method. Brit. Med. J., 1995, 310, 170.
BOELAERT F., BIRONT P., SOUMARE B., DISPAS M., VANOPDENBOSCH E., VERMEERSCH J.-P., RASKIN A., DUFEY J., BERKVENS D., KERKHOFS P. Prevalence of bovine herpesvirus-1 in the Belgian cattle population. Prev. Vet. Med., 2000, 45, 285-295.
BOELAERT F., BERKVENS D., SPEYBROEK N., MINTIENS K., DISPAS M., VERMEERSCH J.-P., KERKHOFS P., DE KRUIF. A. Risk factors associated with Belgian cattle positive to Bovine Herpesvirus-1. In : Gummow B., Mapham P.H., Jack J.B. (Eds.), Proceedings of the 2nd Annual Congress of the Southern African Society for Veterinary Epidemiology and Preventive Medicine, July 22-23 2002. African Society for Veterinary Epidemiology and Preventive Medicine : Onderstepoort, 2002, 21-30.
BOSCH J., KAASHOEK M., KROESE A., VAN OIRSCHOT J. An attenuated bovine herpes-virus 1 marker vaccine induces a better protection than two inactivated marker vaccines. Vet. Microbiol., 1996, 52, 223-234.
BOSCH J., KAASHOEK M., VAN OIRSCHOT J. Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine. Vaccine, 1997, 15, 1512-1517.
BOSCH J., DE JONG M., FRANKEN P., FRANKENA K., HAGE J., KAASHOEK M., MARIS-VELDHUIS M., NOORDHUIZEN J., VAN DER POEL W., VERHOEF J., WEERDMEESTER K., ZIMMER G., VAN OIRSCHOT J. An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field. Vaccine, 1998, 16, 265-271.
BRAR J.S., JOHNSON D.W., MUSCOPLAT C.C., SHOPE R.E., MEISKE J.C. Maternal immunity to infectious bovine rhinotracheitis and bovine viral diarrhea viruses: duration and effect on vaccination in young calves. Am. J. Vet. Res., 1978, 39, 241-244.
DE WERGIFOSSE B., LEMAIRE M., PASTORET P-P., THIRY E. Etablissement d'un plan volontaire de contrôle de la rhinotrachéite infectieuse bovine en Région Wallonne de Belgique. Ann. Méd. Vét., 1997, 141, 185-196.
DISPAS M., SCHYNTS F. , LEMAIRE M., LETELLIER C., VANOPDENBOSCH E., THIRY E., KERKHOFS P. Isolation of a glycoprotein E deleted bovine herpesvirus-1 strain in the field. Vet. Rec., 2003, 153, 209-212.
ENQUIST L.W., HUSAK P., BANFIELD B. & SMITH A. Infection and spread of alphaherpesviruses in the nervous system. Adv. Virus Res., 1999, 51, 237-347.
HILL C., COM-NOUGUE C., KRAMAR A., MOREAU T., O'QUIGLEY J., SENOUSSI R. CHASTANG C. Comparaison de la survie de deux ou plusieurs groupes : approche non paramétrique. In : Hill C., Com-Nougue C., Kramar A., Moreau T., O'Quigley J., Senoussi R. Chastang C., Analyse statistique des données de survie. Flammarion Médecine Sciences: Paris, 1996, 37- 55.
KAASHOEK M.J., MOERMAN A., MADIC J., WEERDMEESTER K., MARIS-VELDHUIS M.A., RIJSEWIJCK F.A.M, VAN OIRSCHOT J.T. An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differenciation. Vaccine, 1995, 13, 343-346.
KAASHOEK M.J., VAN OIRSCHOT J.T. Early immunity induced by a live gE-negative bovine herpesvirus1 marker vaccine. Vet. Microbiol., 1996, 53, 191-197.
KAHRS R.F. Infectious bovine rhinotracheitis : a review and update. J. Am. Vet. Med. Assoc., 1977, 171, 1055-1064.
KAPLAN E., MEIER P. Non parametric estimation from incomplete observations. J. Am. Stat. Assoc., 1958, 53, 457-481.
KERKHOFS P., RENJIFO X., TOUSSAINT J.-F., LETELLIER C. VANOPDENBOSCH E. WELLEMANS G. Inhancement of the immune response and virological protection of calves against bovine herpesvirus type 1 with an inactivated gE-deleted vaccine. Vet. Rec., 2003, 152, 681-686.
LEMAIRE M., PASTORET P.-P., THIRY E. Le contrôle de l'infection par le virus de la rhinotrachéite infectieuse bovine. Ann. Méd. Vét., 1994, 138, 167-180.
LEMAIRE M., MEYER G., ERNST E., VANHERREWHEGE V., LIMBOURG B., PASTORET P.-P., THIRY E. Latent bovine herpesvirus 1 infection in calves protected by colostral immunity. Vet. Rec., 1995, 137, 70-71.
LEMAIRE M., WEYNANTS V., GODFROID J., SCHYNTS F., MEYER G., LEYESSON J.-J., THIRY E. Effects of bovine herpesvirus type 1 infection in calves with maternal antibodies on immune response and virus latency. J. Clin. Microbiol., 2000a, 38, 1485-1494.
LEMAIRE M., MEYER G., BARANOWSKY E., SCHYNTS F., WELLEMANS G., KERKHOFS P., THIRY E. Production of bovine herpesvirus type 1 seronegative latent carriers by administration of a live-attenuated vaccine in passively immunized calves. J. Clin. Microbiol., 2000b, 38, 4233-4238.
LEMAIRE M., F. SCHYNTS, G. MEYER, J.P. GEORGIN, C. ROS, S. BELAK, THIRY E. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies. Vaccine, 2001, 19, 4795-4804.
LIMBOURG B., KERKHOFS P., MASSARD C., MICHELET S., SAEGERMAN C., THIRY E. Avantages et inconvénients d'un plan de lutte contre la rhinotrachéite infectieuse bovine en Belgique. Ann. Méd. Vét., 2002, 147, 57-69.
MAKOSCHEY B., KEIL G.M. Early immunity induced by a glycoprotein E-negative vaccine for infectious bovine rhinotracheitis. Vet. Rec., 2000, 147, 189-191.
MARS M.H., DE JONG M.C.M., FRANKEN P., VAN OIRSCHOT J.T. Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field. Vaccine, 2001, 19, 1924-1930.
MENSIK J., POSPISIL Z., SUCHANKOVA A., CEPICA A., ROZOSNY V ., MACHATKOVA M. Activation of latent infectious bovine rhinotracheitis after experimental infection with parainfluenza 3 virus in young calves. Zentralbl. Vet. Med., 1976, 23B, 854-864.
MINISTERE DES CLASSES MOYENNES ET DE L'AGRICULTURE. Arrêté Royal du 8 août 1997 relatif à la qualification des troupeaux dans la lutte contre la rhinotrachéite infectieuse bovine. Monit. Belge, 1997, 22312-22314.
PASTORET P.-P., THIRY E., BROCHIER B., DERBOVEN G. Bovid herpesvirus 1 infection of cattle : pathogenesis, latency, consequences of latency. Ann. Rech. Vét., 1982, 13, 221-235.
PETO R., PETO J. Asymptotically efficent rank invariant test procedures (with discussion). J. R. Stat. Soc., 1972, 135, 185-207.
PETRIE A., WATSON P. Experimental design and clinical trials. In : Petrie A., Watson P., Statistics for veterinary and animal science. Blackwell Science : London, 1999, 53-65.
SCHYNTS F., LEMAIRE M., BARANOWSKI E., THIRY E. La glycoprotéine gE de l'herpèsvirus bovin de type 1 et les nouveaux vaccins marqués. Ann. Méd. Vét., 1998, 142, 21-32.
TAPINOS G. Les caractéristiques d'une population. In: Tapinos G., Eléments de démographie. Armand Collin: Paris, 1991, 29-44.
THIRY E., DETILLEUX P., DE VRIESE A., PIRAK M., PASTORET P.-P. La rhinotrachéite infectieuse bovine en période néonatale: revue et exposé d'un cas. Ann. Méd. Vét., 1984, 128, 33-40.
THIRY E., SALIKI J., SCHWERS A., PASTORET P.-P. Parturition as a stimulus of IBR reactivation. Vet. Rec., 1985, 116, 599-600.
THIRY E., SALIKI J., BUBLOT M., PASTORET P.-P. Reactivation of infectious bovine rhinotracheitis virus by transport. Comp. Immunol. Microbiol. Infect. Dis., 1987, 10, 59-63.
THIRY E., LEMAIRE M., SCHYNTS F., MEYER G., DISPAS M., GOGEV S. Les conséquences de l'infection des bovins par le virus de la rhinotrachéite infectieuse bovine. Point Vét., 1999, 30, 279-286.
THIRY E. Stratégies de prévention des avortements provoqués par les herpèsvirus et les pestivirus de ruminants. Ann. Méd. Vét., 2002, 146, 161-168.
TOMA B., DUFOUR B., SANAA M., BENET J., SHAW A., MOUTOU F., LOUZA A. Le dépistage des maladies infectieuses animales. In : Toma B., Dufour B., Sanaa M., Benet J., Shaw A., Moutou F., Louza A., Epidémiologie appliquée à la lutte collective contre les maladies animales transmissibles majeures. Association pour l'Etude de l'Epidémiologie des Maladies Animales: Paris, 2001, 41-95.
VAN MALDEREN G., VANOPDENBOSCH E., WELLEMANS G. Bovien herpesvirus 1 en 4: een seroepidemiologisch onderzoek van de Belgische rundveestapel. Diergeneeskd. Tijdschr., 1987, 4, 309-318.
VAN OIRSCHOT J.T., KAASHOEK M.J., MARISVELDHUIS M.A., WEERDMEESTER K., RIJSEWIJK F.A.M. An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle. J. Virol. Methods, 1997, 67, 23-34.
VAN WUIJCKHUISE L., BOSCH J.C., FRANKEN P., FRANKENA K., ELBERS A.R. Epidemiological characteristics of bovine herpesvirus 1 infections determined by bulk milk testing of all Dutch dairy herds. Vet. Rec., 1998, 142, 181-184.
VONK NOORDEGRAAF A., JALVINGH A.W., DE JONG M.C., FRANKEN P., DIJKHUIZEN A.A. Evaluating control strategies for outbreaks in BHV1-free areas using stochastic and spatial simulation. Prev. Vet. Med., 2000, 44, 21-42.
VONK NOORDEGRAAF A. Simulation modelling to support national policy making in the control of bovine herpes virus type 1 (PhD Thesis). Wageningen University : Wageningen, 2002, 168 p. Adresse URL: http://www.gcw.nl/ dissertations/3199/dis3199.pdf Consulté le 23/10/03.
WARD P.I., ROIZMAN B. Herpes simplex genes : the blueprint of a successful human pathogen. Trends Genet., 1994, 10, 267-274
WYLER R., ENGELS M., SCHWYZER M. Infectious bovine rhinotracheitis/vulvo- vaginitis (BHV1). In : Wittmann G. (Eds.), Herpesvirus diseases of cattle, horses and pigs. Kluwer Academic: Boston, 1989, 1-72.
